Hamilton Lane (NASDAQ:HLNE - Get Free Report) had its price objective cut by investment analysts at Morgan Stanley from $190.00 to $157.00 in a note issued to investors on Monday, Marketbeat Ratings reports. The firm currently has an "equal weight" rating on the stock. Morgan Stanley's price objective would suggest a potential upside of 13.99% from the stock's previous close.
Other research analysts have also recently issued reports about the company. The Goldman Sachs Group cut Hamilton Lane from a "neutral" rating to a "sell" rating and set a $139.00 target price on the stock. in a research report on Monday, January 6th. Wells Fargo & Company cut their target price on shares of Hamilton Lane from $152.00 to $147.00 and set an "equal weight" rating for the company in a research report on Tuesday, April 8th. Keefe, Bruyette & Woods lifted their price target on shares of Hamilton Lane from $158.00 to $168.00 and gave the stock a "market perform" rating in a research note on Wednesday, February 5th. Finally, Oppenheimer upgraded Hamilton Lane from a "market perform" rating to an "outperform" rating and set a $186.00 target price on the stock in a research report on Tuesday, January 21st. One research analyst has rated the stock with a sell rating, five have given a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Hold" and an average target price of $165.29.
Read Our Latest Report on HLNE
Hamilton Lane Stock Up 2.0 %
Shares of HLNE stock traded up $2.68 during midday trading on Monday, reaching $137.73. 815,902 shares of the stock were exchanged, compared to its average volume of 422,251. The firm has a market cap of $7.64 billion, a PE ratio of 25.41 and a beta of 1.32. The company has a current ratio of 4.19, a quick ratio of 4.19 and a debt-to-equity ratio of 0.34. The company's 50 day moving average is $147.00 and its two-hundred day moving average is $162.48. Hamilton Lane has a 1 year low of $108.34 and a 1 year high of $203.72.
Hamilton Lane (NASDAQ:HLNE - Get Free Report) last released its earnings results on Tuesday, February 4th. The company reported $1.25 EPS for the quarter, topping analysts' consensus estimates of $1.13 by $0.12. Hamilton Lane had a return on equity of 36.69% and a net margin of 31.12%. The firm had revenue of $168.26 million for the quarter, compared to analysts' expectations of $158.86 million. During the same period in the prior year, the firm posted $0.71 earnings per share. The company's quarterly revenue was up 34.3% on a year-over-year basis. On average, equities research analysts predict that Hamilton Lane will post 4.97 EPS for the current year.
Institutional Investors Weigh In On Hamilton Lane
Several hedge funds have recently modified their holdings of HLNE. FMR LLC raised its stake in Hamilton Lane by 239.9% in the third quarter. FMR LLC now owns 5,557 shares of the company's stock worth $936,000 after buying an additional 3,922 shares in the last quarter. Retirement Systems of Alabama bought a new stake in Hamilton Lane during the third quarter valued at about $8,291,000. Geode Capital Management LLC grew its stake in Hamilton Lane by 2.4% in the third quarter. Geode Capital Management LLC now owns 1,105,063 shares of the company's stock valued at $186,111,000 after purchasing an additional 25,657 shares during the last quarter. Franklin Resources Inc. boosted its holdings in shares of Hamilton Lane by 9.2% in the 3rd quarter. Franklin Resources Inc. now owns 184,836 shares of the company's stock valued at $32,746,000 after buying an additional 15,554 shares in the last quarter. Finally, HighTower Advisors LLC purchased a new position in Hamilton Lane in the third quarter worth $291,000. Hedge funds and other institutional investors own 97.40% of the company's stock.
About Hamilton Lane
(
Get Free Report)
Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.
Featured Articles
Before you consider Hamilton Lane, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hamilton Lane wasn't on the list.
While Hamilton Lane currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
